# Cefazolin

NDC: 0143-9140
Generic name: Cefazolin
Labeler / Manufacturer: Hikma Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20230301

FDA application: NDA216109

## Active ingredients

- CEFAZOLIN SODIUM: 3 g/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0143-9140"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0143-9140
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6c7761d3-c154-4802-9876-627cd42913f0